These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 18331449

  • 1. The clinical and pharmacoeconomic analysis of invasive aspergillosis in adult patients with haematological diseases.
    Cagatay AA, Cosan F, Karadeniz A, Besisik SK, Ozsut H, Nalcaci M, Pekcelen Y, Eraksoy H, Dincol G, Calangu S.
    Mycoses; 2008 Jul; 51(4):328-35. PubMed ID: 18331449
    [Abstract] [Full Text] [Related]

  • 2. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
    Wingard JR, Herbrecht R, Mauskopf J, Schlamm HT, Marciniak A, Roberts CS.
    Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
    [Abstract] [Full Text] [Related]

  • 3. [Invasive pulmonary aspergillosis: a study of 33 cases].
    Ferré A, Domingo P, Alonso C, Franquet T, Gurguí M, Verger G.
    Med Clin (Barc); 1998 Mar 28; 110(11):421-5. PubMed ID: 9608499
    [Abstract] [Full Text] [Related]

  • 4. Management of invasive aspergillosis in high-risk patients.
    Olyaei AJ.
    Manag Care Interface; 2004 Mar 28; Suppl B():7-21; quiz 22-3. PubMed ID: 15115332
    [Abstract] [Full Text] [Related]

  • 5. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
    Rijnders BJ, Cornelissen JJ, Slobbe L, Becker MJ, Doorduijn JK, Hop WC, Ruijgrok EJ, Löwenberg B, Vulto A, Lugtenburg PJ, de Marie S.
    Clin Infect Dis; 2008 May 01; 46(9):1401-8. PubMed ID: 18419443
    [Abstract] [Full Text] [Related]

  • 6. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
    Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R, AmBiLoad Trial Study Group.
    Clin Infect Dis; 2007 May 15; 44(10):1289-97. PubMed ID: 17443465
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II.
    Cancer; 2008 Mar 15; 112(6):1282-7. PubMed ID: 18224662
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM, Solé A, de la Torre M, Pastor A, Fernandez R, Saura A, Delgado M, Monte E, Gonzalez D.
    Transplant Proc; 2008 Nov 15; 40(9):3090-3. PubMed ID: 19010204
    [Abstract] [Full Text] [Related]

  • 11. Caspofungin: new preparation. A last resort in invasive aspergillosis.
    Prescrire Int; 2002 Oct 15; 11(61):142-3. PubMed ID: 12378745
    [Abstract] [Full Text] [Related]

  • 12. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect.
    Soubani AO, Qureshi MA.
    Haematologia (Budap); 2002 Oct 15; 32(4):427-37. PubMed ID: 12803117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N, DePestel DD, Mackler ER, Collins CD, Welch K, Erba HP.
    Pharmacotherapy; 2007 Jul 15; 27(7):970-9. PubMed ID: 17594202
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The value of surgery in the treatment of invasive pulmonary aspergillosis in neutropenic patients].
    Bernard A, Caillot D, Casasnovas O, Couaillier JF, Guy H, Favre JP.
    Rev Mal Respir; 1998 Feb 15; 15(1):49-55. PubMed ID: 9551514
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Invasive aspergillosis in the recipients of liver retransplantation.
    Singh N, Pruett TL, Houston S, Muñoz P, Cacciarelli TV, Wagener MM, Husain S.
    Liver Transpl; 2006 Aug 15; 12(8):1205-9. PubMed ID: 16598780
    [Abstract] [Full Text] [Related]

  • 19. Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional bronchoscopic amphotericin B instillation.
    Winkler J, Müller U, Nenoff P, Seyfarth HJ, Vogtmann M, Borte G, Pönisch W, Kahn T, Wirtz H, Schauer J, Hoheisel G.
    Respiration; 2007 Aug 15; 74(6):663-73. PubMed ID: 17622755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.